Literature DB >> 21879945

Changes in physician costs among high-cost transcendental meditation practitioners compared with high-cost nonpractitioners over 5 years.

Robert E Herron1.   

Abstract

PURPOSE: To determine whether the Transcendental Meditation (TM) technique can affect the physician costs of consistently high-cost people.
DESIGN: Quasi-experimental, longitudinal, cost-minimization evaluation. This 14-year, preintervention-postintervention study retrospectively assessed government payments to physicians for treating the TM and no-treatment (NT) groups.
SETTING: Province of Quebec, Canada. PARTICIPANTS: The highest-spending 10% of 1418 Quebec health insurance enrollees who practiced the TM technique were compared with the highest 10% of 1418 subjects who were randomly selected from enrollees of the same age, sex, and region. TM participants had chosen to begin the technique prior to choosing to enter the study. MEASURES: Annual payments to private physicians in all treatment settings. The Quebec government health insurance agency provided the total physician payments for each of the 2836 subjects from 1981 to 1994. Other medical expense data for individuals were unavailable. Data were adjusted for medical cost inflation. ANALYSIS: For each subject, least-squares regression slopes were calculated to estimate preintervention and postintervention annual rates of change in payments. The groups' means, slopes, and medians were compared using both parametric and nonparametric tests.
RESULTS: Before starting meditation, the yearly rate of increase in payments to physicians between groups was not significantly different. After commencing meditation, the TM group's mean payments declined $44.93 annually (p  =  .004), whereas the NT comparison group's payments exhibited nonsignificant changes. After 1 year, the TM group decreased 11%, and after 5 years their cumulative reduction was 28% (p  =  .001).
CONCLUSIONS: The results suggest the intervention may be an effective method for reducing physician costs. Randomized studies are recommended.

Entities:  

Mesh:

Year:  2011        PMID: 21879945     DOI: 10.4278/ajhp.100729-ARB-258

Source DB:  PubMed          Journal:  Am J Health Promot        ISSN: 0890-1171


  8 in total

1.  Mind-Body Training for At-Risk Populations: Preventive Medicine at its Best.

Authors:  Charles Elder
Journal:  Perm J       Date:  2017

2.  Value associated with mindfulness meditation and moderate exercise intervention in acute respiratory infection: the MEPARI Study.

Authors:  David Rakel; Marlon Mundt; Tola Ewers; Luke Fortney; Aleksandra Zgierska; Michele Gassman; Bruce Barrett
Journal:  Fam Pract       Date:  2013-03-20       Impact factor: 2.267

3.  Cost of opioid-treated chronic low back pain: Findings from a pilot randomized controlled trial of mindfulness meditation-based intervention.

Authors:  Aleksandra E Zgierska; James Ircink; Cindy A Burzinski; Marlon P Mundt
Journal:  J Opioid Manag       Date:  2017 May/Jun

4.  Prevention and Treatment of Cardiovascular Disease in Adolescents and Adults through the Transcendental Meditation(®) Program: A Research Review Update.

Authors:  Vernon A Barnes; David W Orme-Johnson
Journal:  Curr Hypertens Rev       Date:  2012-08

5.  Relaxation Response and Resiliency Training and Its Effect on Healthcare Resource Utilization.

Authors:  James E Stahl; Michelle L Dossett; A Scott LaJoie; John W Denninger; Darshan H Mehta; Roberta Goldman; Gregory L Fricchione; Herbert Benson
Journal:  PLoS One       Date:  2015-10-13       Impact factor: 3.240

Review 6.  Economic Evaluations of Mindfulness-Based Interventions: a Systematic Review.

Authors:  Lingling Zhang; Snehal Lopes; Tara Lavelle; Karyn Ogata Jones; Liwei Chen; Meenu Jindal; Heidi Zinzow; Lu Shi
Journal:  Mindfulness (N Y)       Date:  2022-08-30

7.  Meditation: Process and effects.

Authors:  Hari Sharma
Journal:  Ayu       Date:  2015 Jul-Sep

8.  Transcriptomics of Long-Term Meditation Practice: Evidence for Prevention or Reversal of Stress Effects Harmful to Health.

Authors:  Supaya Wenuganen; Kenneth G Walton; Shilpa Katta; Clifton L Dalgard; Gauthaman Sukumar; Joshua Starr; Frederick T Travis; Robert Keith Wallace; Paul Morehead; Nancy K Lonsdorf; Meera Srivastava; John Fagan
Journal:  Medicina (Kaunas)       Date:  2021-03-01       Impact factor: 2.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.